Shown below are the details for the item you selected from the list.
| File Name |
CMS-5025-N |
| Subject |
Medicare Program; Medicare Replacement Drug Demonstration |
| Publication/Implementation Date |
06/29/2004 |
| Quarterly Release Date |
04/01/2004 |
| Provider Type |
Other CMS Business |
| Type of Regulation |
Regulations Published This Quarter |
| Regulation Summary |
This notice announces the implementation of a demonstration that would pay through December 31, 2005 under Medicare Part B for drugs and biologicals that are prescribed as replacements for existing covered Medicare drugs and biologicals described in section 1861(s)(2)(A) or 1861(s)(2)(Q), or both, of title XVIII of the Social Security Act. Under this demonstration certain self-injected or oral drugs that are not normally covered under Medicare Part B would be covered if they were a replacement for a non self-administered drug or biological normally provided in a physician's office. The statute requires cost sharing in the same manner as Medicare Part D. No more than 50,000 patients may be covered under the demonstration and total funding is limited to $500 million. |
| Additional Information |
N/A |
| | Downloads |
CMS-5025-N [PDF - 291 KB]
| | Related Links Inside CMS |
There are no Related Links Inside CMS
| | Related Links Outside CMS |  |
There are no Related Links Outside CMS
|
|
Last Modified Date : 10/12/2005
Help with File Formats and Plug-Ins
Email
Print